ホーム

Carbetapentane

Carbetapentane

規格

77-23-6CAS番号
201-014-1EC番号
2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylateIUPAC名
C20H31NO3化学式
333.5 g/mol分子量
carbetapentane; Pentoxyverine; 77-23-6; Pentoxiverin; Pentoxyverin; Atussil; Pentoxiverina; Pentoxyverinum; 1-Phenyl-1-cyclopentanecarboxylate; Sedotussin; DTXSID9022734; UCB 2543; 2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate; 2-(Diethylaminoethoxy)ethyl 1-phenyl-1-cyclopentanecarboxylate; 2-(Diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate; 32C726X12W; 1-Phenylcyclopentane-1-carboxylic acid diethylaminoethoxyethyl ester; Ethanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester); DTXCID102734; 1-Phenylcyclopentanecarboxylic acid 2-(2-diethylaminoethoxy)ethyl ester; 1-Phenylcyclopentanecarboxylic acid,2-(2-(diethylamino)ethoxy)ethyl ester; 1-phenylcyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester; 1-phenylcyclopentanecarboxylic acid 2-(2-(diethylamino)ethoxy)ethyl ester; Ethanol, 2-[2-(diethylamino)ethoxy]-, 1-phenylcyclopentanecarboxylate (ester); RefChem:123516; R05DB05; 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate; 201-014-1; 2-(2-(diethylamino)ethoxy)ethyl 1-phenylcyclopentanecarboxylate; U.C.B. 2543; 2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate; CHEMBL73234; Cyclopentanecarboxylic acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester; Pentoxyverine (INN); NCGC00024595-03; Pentoxiverinum; Sedotussin (TN); Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester; PENTOXYVERINE [INN]; Pentoxiverine; 2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate; Pentoxyverine [INN:BAN]; CAS-77-23-6; Pentoxyverinum [INN-Latin]; Pentoxiverina [INN-Spanish]; HSDB 3299; EINECS 201-014-1; BRN 2299701; PENTOXYVERINE (BASE); 2-(2-(diethylamino)ethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; UNII-32C726X12W; CARBAPENTANE; Toclase (Salt/Mix); Tuclase (Salt/Mix); Pentoxyverine Hydrogen; Spectrum_001366; Spectrum_001952; Tocris-0454; Sedotussin (Salt/Mix); Pentoxyverine (Standard); Prestwick0_000387; Prestwick1_000387; Prestwick2_000387; Prestwick3_000387; Spectrum2_001412; Spectrum3_000922; Spectrum4_001021; CARBETAPENTANE [MI]; Cyclopentanecarboxylic acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethylester; PENTOXYVERINE [HSDB]; Lopac0_000313; SCHEMBL67879; BSPBio_000573; KBioGR_001541; KBioSS_001846; KBioSS_002506; cid_90010; CARBETAPENTANE [VANDF]; DivK1c_000356; PENTOXYVERINE [MART.]; SPBio_001484; SPBio_002494; PENTOXYVERINE [WHO-DD]; BPBio1_000631; orb1704841; BDBM94507; CHEBI:94484; KBio1_000356; KBio2_001846; KBio2_002498; KBio2_004414; KBio2_005066; KBio2_006982; KBio2_007634; KBio3_001924; NINDS_000356; HMS5086G10; MSK10300; Tox21_110909; EBC-26624; PDSP1_001673; PDSP2_001656; AKOS015918339; Tox21_110909_1; CCG-204408; DB11186; HY-134004R; SDCCGSBI-0050301.P004; IDI1_000356; NCGC00024595-01; NCGC00024595-02; NCGC00024595-04; NCGC00024595-05; NCGC00024595-06; NCGC00024595-08; NCGC00024595-11; NCGC00024595-15; MS-25033; SBI-0050301.P003; DB-056191; HY-134004; AB00053602; CS-0136428; NS00006529; S0869; D08334; F87719; T22284; AB00053602_09; EN300-18551609; F979288; Q174786; BRD-K06181161-048-04-5; BRD-K06181161-048-07-8; BRD-K06181161-048-15-1; BRD-K06181161-048-16-9; 1-Cyclopentanecarboxylate, 2-(diethylaminoethoxy)ethyl-1-phenyl-; 2-[2-(Diemthylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate; 2-{[2-(diethylamino)ethyl]oxy}ethyl 1-phenylcyclopentanecarboxylate; 1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester; citric acid;1-phenylcyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester; 2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid; 2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate;2-oxidanylpropane-1,2,3-tricarboxylic acid; 2-hydroxypropane-1,2,3-tricarboxylic acid;1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester別名

Carbetapentaneを含む製品